Teva to Present at the Canaccord Genuity 33rd Annual Growth Conference Canaccord Genuity Global Growth Conference 2013 Business Wire JERUSALEM -- August 13, 2013 Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) will host a live audio webcast at the Canaccord Genuity 33^rd Annual Growth Conference in Boston, Massachusetts. Dr. Jeremy M. Levin, President & CEO, will present on Wednesday, August 14, 2013 at 9:30 AM ET. What: Teva Presentation at the Canaccord Genuity 33^rd Annual Growth Conference Who: Dr. Jeremy M. Levin, President & CEO, Teva Pharmaceutical Industries Ltd. When: Wednesday, August 14, 2013 Where: www.tevapharm.com Live over the Internet – log on to the Web at the address above and How: register for the event (approximately 10 minutes before). An archive of the webcast will be available on Teva’s website. About Teva Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world's leading generic drug maker, with a global product portfolio of more than 1,000 molecules and a direct presence in about 60 countries. Teva's branded businesses focus on CNS, oncology, pain, respiratory and women's health therapeutic areas as well as biologics. Teva currently employs approximately 46,000 people around the world and reached $20.3 billion in net revenues in 2012. Contact: Teva Pharmaceutical Industries Ltd. IR Contacts: United States Kevin C. Mannix, 215-591-8912 or Israel Tomer Amitai, 972 (3) 926-7656 or PR Contacts: Israel Iris Beck Codner, 972 (3) 926-7246 or United States Denise Bradley, 215-591-8974
Teva to Present at the Canaccord Genuity 33rd Annual Growth Conference
Press spacebar to pause and continue. Press esc to stop.